Volfi is a Managing Director of Bryant Park Capital’s New York office. He brings with him significant transaction experience (over 70 transactions with approximately $50 billion in aggregate value) in multiple products, including buy-side and sell-side M&A engagements, fairness opinions, and equity and debt capital offerings, across multiples industries, representing both public and private clients.
Prior to joining BPC in 2004, Volfi was Founder and Managing Member of VM Advisors, LLC, a financial services consulting firm, where he advised several public middle market technology companies in their respective sales (over $500 million in value) to strategic buyers. From 1993-2001, Volfi held various positions at Robertson Stephens, a pioneering major bracket investment bank servicing emerging growth companies, including senior roles in the firm’s Communications, Life Sciences, Technology, Healthcare IT and M&A groups. His non-transactional responsibilities included integration of BankBoston’s M&A Group into Robertson Stephens upon their merger and the design and implementation of Robertson Stephens’ analyst and associate training programs.
Notable transactions that Volfi has worked on during his career include Ciba-Geigy Ltd’s investment in and strategic alliance with Chiron Corp.; Monsanto Company’s acquisitions of DEKALB Genetics Corporation, Delta & Pine Land Company and Cargill International Seed Operations; Nellcor Inc.’s merger with Puritan-Bennett Corp.; OnHealth Network Company’s sale to WebMd; strategic alternatives advisory work for Monsanto Company, including its subsequently terminated merger American Home Products Corporation; Sonus Networks, Inc.’s acquisition of Telecom Technologies, Inc.; Alias Research Inc.’s sale to Silicon Graphics, Inc.; PictureTel Corp.’s sale to Polycom Inc.; Digidesign Inc.’s sale to Avid Technology, Inc.; E*Trade Group’s acquisitions of E*Trade UK Limited, E*Trade @ NetBourse SA, and E*Trade Nordic; as well as capital raises for Medicis Pharmaceutical Corporation, US Office Products Company, Duty Free International, Inc., Cypress Semiconductor Corporation, EPIX Medical, and Ariad Pharmaceuticals among others.
Volfi has an MBA from Harvard Business School with honors, and an MS in Electrical Engineering and an MS in Bioengineering from the University of Pennsylvania. Volfi is a graduate of the Jerome Fisher Management & Technology Program at the University of Pennsylvania, where he graduated with honors with a BS Economics from the Wharton School of Business and a BS in Bioengineering from the School of Engineering. Originally from Istanbul, Turkey, Volfi is fluent in English, Turkish, German and French. Volfi is a FINRA registered securities principal (series 24).